Acne, Adult
Conditions
Keywords
skin aging, adult acne
Brief summary
The Embody retinol study is a single-arm clinical trial on skin aging prevention and adult acne. The purpose of this study is to determine the effect of a retinol gummy in adults aged 18-45 on skin aging and overall skin health.
Detailed description
Embody has developed a retinol gummy with the aim to improve the appearance of early signs of aging, such as fine lines, dark spots, and sagging. Embody's retinol gummy has also the goal to reduce the overall frequency of adult acne and an improvement of overall skin health by promoting hydrated, brightened skin. The study aims to collect self-reported outcomes and photographic images to understand the assessment of the efficacy of treatment from the participant's perspective, and if participants see an improvement in their fine lines, wrinkles, dark spots, and sagging.
Interventions
DIETARY_SUPPLEMENTRetinol gummy
Participants take one retinol gummy per day
Sponsors
Citruslabs
Embody Beauty, Inc.
Study design
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
PREVENTION
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
18 Years to 45 Years
Healthy volunteers
Yes
Inclusion criteria
* Male or female between 18-45 years old * Must be in good general health * May experiences adult acne and/or early-stage wrinkles that are not treated by topical or oral prescription drugs/medication * Must maintain a basic skincare routine * Must discontinue the use of other dietary supplements * Must be willing to comply with the requirements of the protocol * Is able to communicate in English * Is willing to skip their normal skincare routine * Must provide written informed consent form (ICF) * Is willing and able to share feedback and take skin pictures via the used technology portal
Exclusion criteria
* Unwilling to provide consent * Unwilling to skip their normal skincare routine * Unwilling to follow the routine of the protocol * Use of other oral retinoids * Use of prescription medication relevant to the skin * Undergoing any cosmetic procedures during the study including Botox, laser or chemical treatments * Deep-set of wrinkles * History of the following medical conditions or diseases: * Kidney disease * Liver disease * Alcohol abuse * Use of prescription drug (topical or oral) that is targeted at any sort of skin condition (for example retinoids) * Any known allergies/sensitivities to nuts
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Skin aging [Time frame: Baseline to 8 weeks] | 8 week intervention period | Patient reported outcome measures (Scale 0-5 with higher scores representing a better outcome) to assess the reduction of early signs of aging such as fine lines, dark spots, and sagging |
| Adult acne [Time frame: Baseline to 8 weeks] | 8 week intervention period | Reduction the overall frequency and intensity of adult acne (Scale 0-5 with higher scores representing a reduction in the appearance of adult acne) |
Countries
United States
Outcome results
None listed